Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

ANDA Stress Test: End-Of-Year Submission Bolus Pressures US FDA Review System

Jan 09 2017

• By Derrick Gingery

Man crushed by Pill

Related Content

Could Drug Price Spikes Spur ANDA Priority Reviews?

Jan 28 2016

ANDA Submission Wave Continues; Is A Crest Near?

Dec 12 2016

Complex ANDAs To Be Allowed Pre-Submission Product Meetings

Oct 24 2016

Generic Reviews Steaming Ahead, But Are Storm Clouds On The Horizon?

Feb 25 2016

Dark, Then Dawn: ANDA Workload Approaching Steady State After 2014 Eruption

Mar 28 2016

ANDA Avalanche: How Will FDA Deal With The 600 Received This Month?

Jun 30 2014

GDUFA Performance Goals For Fiscal Years 2013-2017

Dec 12 2011

Generic Application Quality Showing Signs Of Improvement

Jan 05 2017

US FDA Might Be Temporarily Headed By Ostroff As Califf Sets His Departure

Jan 05 2017

ANDA Approvals, Complete Responses Hit Record In FY 2016

Oct 12 2016

FDA Aims To 'Pierce The Rhetoric' On Generic Application Backlog

Oct 31 2016

ANDAs Can Get Priority, Eight-Month Reviews Under User Fee Deal

Sep 24 2016

Additional Topics

United States Generic Drugs Drug Review Regulation FDA Review Pathway BioPharmaceutical

More from Generics

More from Biosimilars & Generics

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window